385 related articles for article (PubMed ID: 29902448)
21. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
[TBL] [Abstract][Full Text] [Related]
22. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI
Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
[TBL] [Abstract][Full Text] [Related]
23. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
24. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
[TBL] [Abstract][Full Text] [Related]
25. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization.
Ruma MS; Moise KJ; Kim E; Murtha AP; Prutsman WJ; Hassan SS; Lubarsky SL
Am J Obstet Gynecol; 2007 Feb; 196(2):138.e1-6. PubMed ID: 17306655
[TBL] [Abstract][Full Text] [Related]
26. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
27. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
[TBL] [Abstract][Full Text] [Related]
28. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
29. Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and newborn.
Maisonneuve E; Toly-Ndour C; Jouannic JM
Am J Obstet Gynecol; 2019 Mar; 220(3):288. PubMed ID: 30837065
[No Abstract] [Full Text] [Related]
30. [Analysis and perinatal outcome after intravascular transfusion].
Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E
Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion: a new approach in the management of severe Rh-immunization.
Deka D; Buckshee K; Kinra G
J Obstet Gynaecol Res; 1996 Dec; 22(6):561-7. PubMed ID: 9037945
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulation for early-onset haemolytic disease of the fetus/newborn: Can we delay the need for intrauterine transfusions?
Moise KJ
Br J Haematol; 2023 Jan; 200(1):11-12. PubMed ID: 36128877
[TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation.
Vlachodimitropoulou E; Lo TK; Bambao C; Denomme G; Seaward GR; Windrim R; Tessier F; Kelly E; Van Mieghem T; Ryan G
Br J Haematol; 2023 Jan; 200(1):100-106. PubMed ID: 36100813
[TBL] [Abstract][Full Text] [Related]
34. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
[TBL] [Abstract][Full Text] [Related]
35. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
[TBL] [Abstract][Full Text] [Related]
36. Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital.
Sánchez-Durán MÁ; Higueras MT; Halajdian-Madrid C; Avilés García M; Bernabeu-García A; Maiz N; Nogués N; Carreras E
BMC Pregnancy Childbirth; 2019 Oct; 19(1):356. PubMed ID: 31615430
[TBL] [Abstract][Full Text] [Related]
37. Intraperitoneal and intracardiac transfusion of recurrent fetal erythroblastosis due to anti-M alloimmunization with unfavorable outcome.
Lin TH; Shih JC; Lin CH; Lin SY; Su YN; Lee CN
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):253-5. PubMed ID: 22795103
[TBL] [Abstract][Full Text] [Related]
38. Relationship between obstetric history and Rh(D) alloimmunization severity.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
[TBL] [Abstract][Full Text] [Related]
39. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization.
Deka D; Dadhwal V; Sharma AK; Shende U; Agarwal S; Agarwal R; Vanamail P
Arch Gynecol Obstet; 2016 May; 293(5):967-73. PubMed ID: 26493554
[TBL] [Abstract][Full Text] [Related]
40. Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies.
Murphy MF; Waters AH; Doughty HA; Hambley H; Mibashan RS; Nicolaides K; Rodeck CH
Transfus Med; 1994 Dec; 4(4):281-92. PubMed ID: 7889140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
